|
|
|
|
|
Press Release |
|
|
| 04/27/2009 | Bacilligen, Inc. To Develop Influenza Vaccine
Bacilligen Receives NIH Grant to Develop Rapid Response Vaccine Vector Platform.
| | 06/20/2007 | Bacilligen, Inc. Receives Investment From Maryland Department of Business and Economic Development Challenge Investment Program
Bacilligen announces they have accepted a $50,000 investment from the State's Challenge Investment Program fund.
| | 01/30/2008 | Bacilligen, Inc. Files Patent Applications On BVS Recombinant Capsid Vector Technology and rMB Improved Bladder Cancer Therapy
Bacilligen, Inc. announced today that it has filed patent applications covering two of its platform technologies.
| | 11/12/2007 | Bacilligen, Inc. Receives NIH Grant To Develop Improved Therapy For Bladder Cancer
Bacilligen announces they have accepted a $50,000 investment from the State's Challenge Investment Program fund.
| | 06/17/2008 | Bacilligen, Inc. to Present at BIO 2008 International Convention
Bacilligen, Inc. announced today it is presenting at the BIO 2008 International Convention taking place June 17-20th in San Diego, California.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|